Answers are grounded in this paper and cite their sources.
We have identified a nuclear-matrix-associated, Bcell-restricted regulator of IgH transcription (Bright)(Herrscher et al. 1995). Bright binds and trans-activatesvia specific A/T-rich sequences (MARs) within and necessary for nuclear matrix attachment of the IgH intronicenhancer (Eµ). We have found that a previously identified protein, Cux/CDP, which resides within matrices ofnon-B and early lineage-B (pre-B) cells, represses Eµ viathe same binding sites bound by Bright in more differentiated B cells (Wang et al. 1999). Cux can effectively antagonize Bright binding and trans-activation and appearsto comprise (at least in part) a previously identified protein/DNA complex, NF-µNR (nuclear factor implicatedin µ IgH negative regulation) (Scheuermann and Chen1989). We hypothesize that the reciprocal action of thesefactors contributes to the cell-type-restricted on/off stateof Eµ and to the increase in Eµ activity during B-cell lineage development/differentiation. We suggest that anovel and potentially rate-limiting consequence is toswitch the balance of IgH nuclear matrix attachment.Here, we discuss the structure, function, and expressionof Bright, Cux/CDP, and molecules that interact withthem in the context of this model...
No takes yet. Share an insight, caveat, or question.
Webb et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: